These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34707356)

  • 1. Heptamethine Cyanine Dye MHI-148-Mediated Drug Delivery System to Enhance the Anticancer Efficiency of Paclitaxel.
    Raveendran A; Poilil Surendran S; Ser J; Alam K; Cho H; Jeong YY
    Int J Nanomedicine; 2021; 16():7169-7180. PubMed ID: 34707356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHI-148 Cyanine Dye Conjugated Chitosan Nanomicelle with NIR Light-Trigger Release Property as Cancer Targeting Theranostic Agent.
    Thomas RG; Moon MJ; Surendran SP; Park HJ; Park IK; Lee BI; Jeong YY
    Mol Imaging Biol; 2018 Aug; 20(4):533-543. PubMed ID: 29450802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Therapeutic Potential of Farnesylthiosalicylic Acid: Tumor Specific Delivery via Conjugation with Heptamethine Cyanine Dye.
    Guan Y; Zhang Y; Xiao L; Li J; Wang JP; Chordia MD; Liu ZQ; Chung LW; Yue W; Pan D
    Mol Pharm; 2017 Jan; 14(1):1-13. PubMed ID: 26992462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-Infrared Heptamethine Cyanine Based Iron Oxide Nanoparticles for Tumor Targeted Multimodal Imaging and Photothermal Therapy.
    Lee S; George Thomas R; Ju Moon M; Ju Park H; Park IK; Lee BI; Yeon Jeong Y
    Sci Rep; 2017 May; 7(1):2108. PubMed ID: 28522841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of a paclitaxel-loaded low molecular weight heparin-all-trans-retinoid acid conjugate ternary nanoparticulate drug delivery system.
    Hou L; Yao J; Zhou J; Zhang Q
    Biomaterials; 2012 Jul; 33(21):5431-40. PubMed ID: 22521488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer.
    Xue J; Li R; Gao D; Chen F; Xie H
    Int J Nanomedicine; 2020; 15():5701-5718. PubMed ID: 32848392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated-Paclitaxel and Dihydroartemisinin Nanoparticles for Simultaneously Delivering Paclitaxel and Dihydroartemisinin to Colorectal Cancer.
    Phung CD; Le TG; Nguyen VH; Vu TT; Nguyen HQ; Kim JO; Yong CS; Nguyen CN
    Pharm Res; 2020 Jun; 37(7):129. PubMed ID: 32548664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
    Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
    J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy.
    Shan L; Cui S; Du C; Wan S; Qian Z; Achilefu S; Gu Y
    Biomaterials; 2012 Jan; 33(1):146-62. PubMed ID: 21959006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
    Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
    Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution.
    Saravanakumar G; Min KH; Min DS; Kim AY; Lee CM; Cho YW; Lee SC; Kim K; Jeong SY; Park K; Park JH; Kwon IC
    J Control Release; 2009 Dec; 140(3):210-7. PubMed ID: 19560497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C; Liu W; Hu Y; Li W; Di W
    Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Florescence Imaging Lung Cancer with a Small Molecule MHI-148.
    Xia X; Gai Y; Feng H; Qin C; Pan D; Song Y; Zhang Y; Lan X
    J Fluoresc; 2020 Dec; 30(6):1523-1530. PubMed ID: 32780263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid.
    Yin S; Huai J; Chen X; Yang Y; Zhang X; Gan Y; Wang G; Gu X; Li J
    Acta Biomater; 2015 Oct; 26():274-85. PubMed ID: 26300335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice.
    Dalela M; Shrivastav TG; Kharbanda S; Singh H
    ACS Appl Mater Interfaces; 2015 Dec; 7(48):26530-48. PubMed ID: 26528585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring.
    Kim K; Kim JH; Park H; Kim YS; Park K; Nam H; Lee S; Park JH; Park RW; Kim IS; Choi K; Kim SY; Park K; Kwon IC
    J Control Release; 2010 Sep; 146(2):219-27. PubMed ID: 20403397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides.
    Sun J; Jiang L; Lin Y; Gerhard EM; Jiang X; Li L; Yang J; Gu Z
    Int J Nanomedicine; 2017; 12():1517-1537. PubMed ID: 28280323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.